Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Varicella Zoster Immune Globulin (Human) VariZIG in Patients at Risk of Varicella Infection

NCT00338442 is registered in ClinicalTrials.gov with Cangene Corporation as lead sponsor.

NCT NCT00338442
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00338442 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Varicella Zoster Immune Globulin (Human) VariZIG in Patients at Risk of Varicella Infection
Lead sponsor
Cangene Corporation
Phase
Expanded access
Overall status
Approved for marketing
Start date
February 28, 2006
Completion date
December 31, 2009
Enrollment
Not reported
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

varicella